Kyverna Therapeutics · 3 weeks ago
Medical Affairs Writer - Contract
United States
Contract
Remote
Senior Level, Lead/Staff
$90/hr - $110/hr
10+ years expKyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. They are seeking a Medical Communications Medical Affairs Writer (Contract) responsible for the development, coordination, and execution of high-quality scientific publications and medical content that communicate clinical and translational data accurately and effectively.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Support the development and execution of the global medical communication and publication plans aligned with Medical Affairs and clinical program objectives
Author, edit, and manage a range of publication and other medical communication deliverables, including:
Primary manuscripts
Review articles
Abstracts
Slide Decks (MSL and HCP)
Congress posters and oral presentations
Plain language summaries (as applicable)
Ensure content is scientifically accurate, balanced, and aligned with source data
Translate complex clinical, preclinical, and translational data into clear, compelling scientific narratives
Manage internal review, approval workflows, and version control
Partner with Clinical Development, Biostatistics, Regulatory, Commercial (as appropriate), and external medical writers
Support author engagement, including coordinating feedback and revisions with key opinion leaders (KOLs)
Inquiry management – Monitor the inquiry inbox and respond to patient and physician inquiries using approved templates
Qualification
Required
Advanced degree in a scientific or medical discipline (PhD, PharmD, MD, or MS with relevant experience)
10+ years of medical or scientific writing experience in publications within biotech, pharma, or medical communications
Demonstrated experience authoring manuscripts, abstracts, and congress materials
Strong understanding of clinical trial design, statistics, and data interpretation
Working knowledge of publication ethics and guidelines (ICMJE, GPP)
Experience supporting publications for cell therapy, immunology, or rare/autoimmune diseases
Exceptional scientific writing and editing skills
Strong project management and organizational abilities
Ability to work independently while collaborating effectively across functions
High attention to detail and commitment to quality and compliance
Clear communicator with the ability to manage competing priorities
Company
Kyverna Therapeutics
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$295MKey Investors
Oxford Finance LLCNorthpond Ventures
2025-12-17Post Ipo Equity· $100M
2025-11-03Post Ipo Debt· $25M
2024-02-08IPO
Leadership Team
Marc Grasso
Chief Financial Officer
Tom Van Blarcom
Senior Vice President, Head of Research
Recent News
2026-01-02
2025-12-17
Company data provided by crunchbase